Method for measuring an immunologically active material and apparatus suitable for practising said method

Abstract: There are provided a method and an apparatus for measuring an immunologically active material by physically or chemically immobilizing a material being immunologically active to a material to be measured of a specimen onto dehydrated solid fine particles, providing a desired dispersed body of said immunologically active material immobilized onto said solid fine particles in a dispersing medium, adding the specimen to said dispersed body while stirring to react the specimen with the immologically active material, whereby causing a reaction mixture in an agglutinated state and optically measuring said agglutinated state of the reaction mixture to thereby quantitatively determine the content of the material to be measured with an improved accuracy.

Description: FIELD OF THE INVENTION The present invention relates to a method and an apparatus for measuring an immunologically active material such as antigen or antibody contained in a specimen with the use of dehydrated solid fine particles (hereinafter referred to as "dry solid fine particles"). More particularly, the present invention relates to a method and an apparatus for optically measuring said immunologically active material wherein dry solid fine particles having an immunologically active material immobilized on their surfaces are used and the agglutination degree of a product resulted as a result of antigen-antibody reaction is optically measured. BACKGROUND OF THE INVENTION A latex agglutination immunoassay method (LAIA method) was developed by J. M. Singer et al [see, Am. J. Med., 21888 (1956)]. In the LAIA method, a dispersion (latex reagent) obtained by dispensing an immunologically active material such as antibody being disposed on fine particles of polystyrene in a liquid medium such as water is effected with a material having a selective reactivity such as antibody to said immunologically active material to cause an agglutinated body and the agglutinated state of the resultant is observed by eyes to thereby recognize the presence of the material to be observed. Since then, there have been made various studies on this method. Although quantitative determination is difficult, said method of recognizing the presence of an objective material by observing the agglutinated state of such agglutinated body by eyes has been widely used since the method is simple and provides a result for a short period of time. In order to obtain a precise result, there was made an attempt to observe the agglutinated degree of the agglutinated body by an optically measuring means. For instance, A. Fature et al proposed a method of optically observing a change in the turbidity caused by agglutination reaction and performing quantitative determination of an objective material based on the dynamic analysis [see, Protides Biol Fluids, Proc. Colloq., 2589 (1972)]. This method is however problematic in that the values obtained will be greately varied because of unstableness of a latex reagent to be used and the method is not sufficient in the measuring sensitivity. More particularly with respect to the method of A. Fature et al., the latex reagent used is of a state that solid fine particles are dispersed in a liquid dispersing medium and it is substantially unstable. And there are problems for the latex reagent in that it is likely to cause agglutination and/or reduction in its sensitivity upon storage for a long period of time, the dispersed state thereof will be destroyed upon cryopreservation and thus, specific due regards should be made upon its storage in order to prevent occurrence of these problems. In order to eliminate the above problems of the latex reagent, there was made a proposal of freeze-drying the latex reagent comprising solid fine particles dispersed in a liquid dispersing medium to maintain its stability upon storage by Japanese Unexamined Patent Publication 52(1977)-117420 or 62(1987)-46262. According to this proposal, there is an advantage that the stability upon storage of the latex reagent is improved. However, there are still unsolved problems in that a latex reagent obtained by redispersing the dried product in a liquid dispersing medium is not always constant in the agglutination reactivity and because of this, there is caused a variation for the resulting measured data. In view of the above, according to such known method, it is possible to qualitatively detect the presence of an objective material contained in a specimen, but it is extremely difficult to quantitatively measure said material with a high accuracy. Now, there is another proposal for detecting an immunologically active material contained in a specimen by injecting an agglutinated immune reagent such as latex reagent into a capillary tube, followed by freeze-drying, mixing the resultant with a specimen in said capillary tube, reacting them to cause an agglutinated body and observing the agglutinated state of said body (see, Japanese Unexamined Patent Publication 58(1983)-73866). This method is advantageous in the viewpoints that the reagent is stably maintained upon storage and the procedures are simple. However, this method is still problematic in that the reproducibility of a measured value is not sufficient and it is difficult to perform precise quantitative determination of an objective material contained in a specimen. SUMMARY OF THE INVENTION The present invention makes it an object to eliminate the foregoing problems in the prior arts and to provide an improved immunologically measuring method which excels in the reproducibility of a measured value and makes it possible to quantitatively measure an immunologically active material contained in a specimen with a high accuracy. Another object of the present invention is to provide an improved immunologically measuring method which makes it possible to quantitatively measure an immunologically active material such as antigen, antibody, etc. contained in a specimen with an improved accuracy by utilizing the antigen-antibody reaction wherein a specific dehydrated immune reagent is used. A further object of the present invention is to provide an improved immunologically measuring method which makes it possible to quantitatively measure an immunologically active material such as antigen, antibody, etc. contained in a specimen with an improved accuracy wherein a specific dehydrated immune reagent is used and the stirring upon preparing a dispersion of fine particles of said reagent by subjecting said fine particles to redispersion in a dispersing medium is properly controlled by optically observing the dispersed state of said fine particles, whereby causing agglutination reaction in a desirable state, and providing marked improvements in reproducibility and reliability of data obtained. A further object of the present invention is to provide an improved immunologically measuring method which makes it possible to quantitatively measure an immunologically active material such as antigen, antibody, etc. contained in a specimen with an improved accuracy within a short period of time. A still further object of the present invention is to provide an apparatus suitable for practicing the foregoing immunologically measuring method. BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic explanatory view of the constitution of a representative apparatus suitable for practicing the immunologically measuring method of the present invention. FIG. 2 is a schematic explanatory view of the constitution of another representative apparatus suitable for practicing the immunologically measuring method of the present invention. FIG. 3 is a view showing changes in the permeability in respective steps of the immunologically measuring method according to the present invention. FIG. 4 is a schematic flow chart of a first embodiment of the immunologically measuring method according to the present invention. FIG. 5 is a schematic flow chart of a second embodiment of the immunologically measuring method according to the present invention. FIGs. 6 to 8 are views respectively showing the interrelation between the stirring period and the ratio A/Ao obtained in the experiments with respect to the first embodiment of the immunologically measuring method according to the present invention. FIGs. 9 to 11 are views respectively showing the interrelation between the stirring period and the ratio A/Ao obtained in the experiments with respect to the second embodiment of the immunologically measuring method according to the present invention. DETAILED DESCRIPTION OF THE INVENTION The present inventors have made extensive studies for overcoming the foregoing problems in the prior arts and attaining the objects as described above and as a result, have accomplished the present invention based on the findings as below described. That is, as a result of experimental studies on the foregoing problems in the known measuring method using a dehydrated reagent,the present inventors have found the facts that the reason of causing changes in the measured values in the known measuring method is not only due to unevenness of the dispersed state of a redispersed body but also due to reduction in the measuring sensitivity caused by destruction of the connection of an immunologically active material to the solid fine particles because of continuous stirring for a long period of time or excessively strong stirring for the redispersion. Then, the present inventors have made further experimental studies based on the foregoing findings, and as a result, have found the facts that in the step of redispersing a dehydrated reagent in a dispersing medium, when stirring is performed while optically observing the dispersed state of the resulting redispersed body and the successive step is performed upon providing a desirable dispersed state for the redispersed body, the situation becomes such that allows stable quantitative measurement of an objective material to be measured with a greately improved measuring sensitivity. The present invention has been accomplished based on the above findings and provides an improved method for immunologically measuring an immunologically active material (hereinafter referred to as "improved immunologically measuring method") and an apparatus suitable for practicing said method (hereinafter referred to as "immunologically measuring apparatus"). The immunologically measuring method according to the present invention includes the following two embodiments. The first embodiment of the immunologically measuring method of the present invention is directed to a method for measuring an immunologically active material by physically or chemically connecting a material immunologically active to a material to be measured contained in a specimen to solid fine particles, reacting said immunologically active material connected to said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state and optically measuring said agglutinated state of the reaction mixture, characterized by including the steps of: (i) introducing a dispersing medium into a measuring cell containing dehydrated solid fine particles having a material immunologically active to a material to be measured contained in a specimen being physically or chemically immobilized onto the surfaces of said solid fine particles (these dehydrated solid fine particles will be hereinafter referred to as "dry reagent fine particles"), (ii) stirring said dispersing medium and said dry reagent fine particles while optically measuring the state of said dry reagent fine particles being dispersed in said dispersing medium, (iii) observing the dispersed state of said dry reagent fine particles in said dispersing medium on the basis of the optically measured results obtained in the step (ii) and terminating the stirring of the step (ii) when said dispersed state becomes to be a predetermined dispersed state, (iv) adding said specimen to the dispersed body in said predetermined dispersed state, mixing and reacting them to cause a reaction mixture in an agglutinated state, and (v) optically measuring the agglutinated state of the reaction mixture, wherein the step (iii) of observing the dispersed state of the dry reagent fine particles in the dispersing medium is performed by confirming if the ratio of an index A obtained by the equation (1): A=logIo/I versus an index Ao obtained by the equation (2): Ao=logI'o/I' satisfies the equation: A/Ao≦1.1, wherein the equation (1) is of the dry reagent particles dispersed body obtained in the step (ii), Io is an intensity of incident monochromatic light upon passing through the measuring cell containing said dispersed body and I is an intensity of light transmitted or scattered at that time, and wherein the equation (2) is of the reference standard dry reagent particles dispersed body, I'o is an intensity of incident monochromatic light upon passing through the measuring cell containing said standard dispersed body and I' is an intensity of light transmitted or scattered at that time. The second embodiment of the immunologically measuring method of the present invention is directed to a method for measuring an immunologically active material by physically or chemically connecting a material immunologically active to a material to be measured contained in a specimen to solid fine particles, reacting said immunologically active material connected to said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state and optically measuring said agglutinated state of the reaction mixture, characterized by including the steps of: (i) introducing a dispersing medium into a reaction cell containing dehydrated solid fine particles having a material immunologically active to a material to be measured contained in a specimen being physically or chemically immobilized onto the surfaces of said solid fine particles (these dehydrated solid fine particles will be hereinafter referred to a "dry reagent fine particles"), (ii) stirring said dispersing medium and said dry reagent fine particles while optically measuring the state of said dry reagent fine particles being dispersed in said dispersing medium, (iii) observing the dispersed state of said dry reagent fine particles in said dispersing medium on the basis of the optically measured results obtained in the step (ii) and terminating the stirring of the step (ii) when said dispersed state becomes to be a predetermined dispersed state, (iv) adding said specimen to the disposed body in said predetermined dispersed state, mixing and reacting them to cause a reaction mixture in an agglutinated state, (v) flowing the reaction mixture caused in the reaction cell in the step (iv) into a measuring cell, and (vi) optically measuring the agglutinated state of the reaction mixture in the measuring cell, wherein the step (iii) of observing the dispersed state of the dry reagent fine particles in the dispersing medium is performed by confirming if the ratio of an index A obtained by the equation (1): A=logIo/I versus an index Ao obtained by the equation (2): Ao=logI'o/I' satisfies the equation: A/Ao≦ 1.1, wherein the equation (1) is of the dry reagent particles dispersed body obtained in the step (ii), Io is an intensity of incident monochromatic light upon passing through the reaction cell containing said dispersed body and I is an intensity of light transmitted or scattered at that time, and wherein the equation (2) is of the reference standard dry reagent particles dispersed body, I'o is an intensity of incident monochromatic light upon passing through the reaction cell containing said standard dispersed body and I' is an intensity of light transmitted or scattered at that time. The main feature of the immunologically measuring method including the foregoing two embodiments according to the present invention lies in that a specific dehydrated immune reagent comprising dehydrated solid fine particles having a material, which is immunologically active to a material to be measured, contained in a specimen, being immobilized onto the surfaces of said solid fine particles is used and in the step of subjecting said dehydrated immune reagent to redispersion in a dispersing medium while stirring, the stirring is properly controlled such that a desirable dispersed body is provided without causing reduction in the sensitivity of the immune reagent for a short period of time, depending upon optical data obtained by optically measuring the dispersed state of the resulting dispersed body. Because of this, there is afforded a redispersed body of said dehydrated immune reagent in a desirable dispersed state within a short period of time and this result in causing smooth agglutination reaction. Thus, the immunologically measuring method according to the present invention excels in the reproducibility of a reliable measured value and makes it possible to quantitatively measure an immunologically active material such as antigen, antibody, etc. contained in a specimen with an improved accuracy within a short period of time. Further, the immunologically measuring method of the present invention is advantageous with the point that the quality and the sensitivity of the foregoing dispersed body is stably maintained during the quantitatively measuring process because of using the foregoing specific immune reagent comprising dehydrated solid particles having a material, which is immunologically active to a material to be measured contained in a specimen, being immobilized onto the surfaces of said solid fine particles, which does not cause such natural agglutination as will be caused in the case of an immune reagent dispersed in water in the prior arts as time lapses, which does not require any particular due regard for its storage (in the case of a known immune reagent, it can not be freeze-dried and a particular due regard is required for its storage), and which is stably maintained even upon storage for a long period of time. The immunological measuring method including the foregoing first and second embodiments according to the present invention may be properly practiced by using an appropriate apparatus. As for the first embodiment of the immunologically measuring method according to the present invention, it can be effectively practiced by using an apparatus having the constitution embodied in the following Apparatus Example 1 or 2. Apparatus Example 1 An apparatus for measuring an immunologically active material by physically or chemically immobilizing a material immunologically active to a material to be measured contained a specimen to solid fine particles, reacting said immunologically active material immobilized onto said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state in a measuring cell and optically measuring the agglutinated state of said reaction mixture in said measuring cell, said apparatus comprises: means for supporting said measuring cell containing said solid fine particles, means for injecting a dispersing medium into the measuring cell, means for injecting a specimen into the measuring cell, a first stirring means for stirring the contents in the measuring cell, a second stirring means for stirring the contents in the measuring cell, a measuring system for optically measuring the agglutinated degree of the contents in the measuring cell, and a control system of demanding continuation or termination of the stirring based on optical data obtained about the dispersed state of the stirred contents in the measuring cell. Apparatus Example 2 An apparatus for measuring an immunologically active material by physically or chemically immobilizing a material immunologically active to a material to be measured contained in a specimen to solid fine particles, reacting said immunologically active material immobilized onto said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state in a measuring cell and optically measuring the agglutinated state of said reaction mixture in said measuring cell, said apparatus comprises: means for supporting said measuring cell containing said solid fine particles, means for injecting a dispersing medium into the measuring cell, means for injecting a specimen into measuring cell, a stirring means for stirring the contents in the measuring cell, a mechanism for changing the stirring competence of said stirring means, a measuring system for optically measuring the degree of the agglutinated state of the contents in the measuring cell, and a control system of demanding continuation or termination of the stirring based on optical data obtained about the dispersed state of the stirred contents in said measuring cell. As for the second embodiment of immunologically measuring method according to the present invention, it can be effectively practiced by using an apparatus having the constitution embodied in the following Apparatus Example 3. Apparatus Example 3 An apparatus for measuring an immunologically active material by physically or chemically immobilizing a material immunologically active to a material to be measured contained in a specimen to solid fine particles, reacting said immunologically active material immobilized onto said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state in a reaction cell and optically measuring said agglutinated state of the reaction mixture, said apparatus comprises: means for supporting said reaction cell containing said solid fine particles, means for injecting a dispersing medium into the reaction cell, means for injecting said specimen into the reaction cell, a first stirring means for stirring the contents in the reaction cell, a second stirring means for stirring the contents in the reaction cell, a measuring system for optically measuring the degree of the dispersed state of the stirred solid fine particles in said dispersing medium in the reaction cell, a control system of demanding continuation or termination of the stirring based on optical data obtained about said dispersed state of the solid fine particles, a measuring cell for measuring the reaction mixture being supported by a measuring cell-supporting means, means for introducing the reaction mixture into said measuring cell, and a system for measuring the degree of the agglutinated state of the reaction mixture introduced into said measuring cell. In the following, the present invention will be more detailed explained. As the foregoing solid fine particles to be used in the present invention, there can be illustrated solid fine particles originated in a living thing (hereinafter referred to as "bacteria solid fine particles"), solid fine particles of an inorganic material (hereinafter referred to as "inorganic solid fine particles"), and solid fine particles of an organic material (hereinafter referred to as "organic solid fine particles"). Specific examples of said bacteria solid fine particles are solid fine particles of fungus body of bacteria such as staphylococcus, streptococcus, etc. which was applied with red cell dispersion treatment. Specific examples of said inorganic solid fine particles are solid fine particles of silica, alumina, bentonite, etc. Specific examples of said organic solid fine particles are solid fine particles of a single-polymer of a vinyl monomer such as styrene, vinyl chloride, acrylonitrile, vinyl acetate, acrylic ester, methacrylic ester, etc.; solid fine particles of copolymers of said monomers; and solid fine particles of butadienic copolymers such as methyl methacrylate-butadiene copolymer. The immobilization of an immunologically active material onto these solid fine particles is performed through physical or chemical connection. In the case of immobilizing the immunologically active material through physical connection onto the solid fine particles, the solid fine particles are desired to have hydrophobic surfaces. For this purpose, solid fine particles of polymer comprising styrene monomer, solid fine particles of vinylic copolymer containing styrene as the main constituent, and solid fine particles of styrene-butadiene copolymer containing styrene as the main constituent are the most desirable. As for the particle size in terms of a mean value with respect to each of the foregoing bacteria solid fine particles, inorganic solid fine particles and organic solid fine particles, it is desired to be preferably in the range of from 0.05 to 5 µm, most preferably in the range of from 0.1 to 2 µm. In any case, if the mean particle size is less than 0.05 µm, it is difficult for the dehydrated reagent to be dispersed in a desirable state in a dispersing medium. On the other hand, when the mean particle size is exceeding 5 µm, the stability of the resulting dispersed body will be poor. As the immunologically active material to be physically or chemically immobilized onto the surfaces of the foregoing solid fine particles, there is selectively used such a material which causes antigen-antibody reaction with a material to be measured, contained in a specimen. As such material, there can be mentioned immune globulins such as IgG, IgM, IgE, etc.; plasma proteins and antibodies thereof such as complement, CRP, ferritin, α 1 -microglobulin, β 2 -microglobulin, etc.; neoplasma markers and antibodies thereof such as -fetoprotein, carcino-embryonic antigen (EA), prostatic acid phosphatase (PAP), CA-19-9, CA-125, etc.; hormones and antibodies thereof such as luteinizing hormone (LH), folliale-stimulating hormone (FSH), human chorionic gonadotropin (hCG), estrogen, insulin, etc.; virus infection-related materials and antibodies, thereof such as HBV-related antigens (HBs, HBe, HBc), HIV, ATL, etc.; bacteria and antibodies thereof such as diphtheroid, botulinus bacillus, mycoplasma, treponema pallidum, etc.; protozoans and antibodies thereof such as toxoplasma, tricomonas leishmania, tripanosoma, plasmodium, etc.; antiepiletic medicines such as phenitoin, phenobarbital, etc.; cardiovascular medicines such as quinidine, digoxinine, etc.; antiasthma medicines such as theophydline, etc.; antibiotics and antibodies thereof such as chloramphenicol, gentamicin, etc.; and other than these, other enzmes, exobacterial toxins, and antibodies of them. Among these immunologically active material, hCG antibody, CRP antibody, β 2 -microglobulin antibody and α-fetoprotein are particularly effective. The immobilization of any of these immunologically active material onto the foregoing solid fine particles can be performed by such a conventional physically connecting method or/and such a conventional chemically connecting method as disclosed Japanese Unexamined Patent Publication 53(1978)-52620 or Japanese Patent Publication 53(1978)-12966. In a preferred embodiment in the case of chemically connecting the immunologically active material onto the solid fine particles through chemical reaction, this connection process is desired to be carried out in water or a mixed solvent comprising water and a solvent compatible with water such as alcohol or ketone. And, in order to stabilize the solid fine particles and also in order to prevent occurrence of non-specific agglutination, it is preferred to add a buffer solution such as phosphate buffer solution, physiologic salt solution, and Tris-HCL buffer solution, an inactive protein such as bovine serum albumin, or a surface active agent to the reaction system. As for the PH value of the reaction system, it is desired to be adjusted preferably at a value of 6 to 10, more preferably at a value of 7 to 9. And, as for the content of the solid fine particles in the reaction system, it is desired to be adjusted preferably in the range of 0.01 to 2.0% by weight. In a preferred embodiment of chemically connecting the immunologically active material onto the solid fine particles, one of the following two methods (i) and (ii) is employed. That is, (i) a method of chemically reacting the immunologically active material with the surfaces of the solid fine particles through polyamide compound having amino group, carboxyl group or oxirane group being oriented, polyimide compound, polyaldehyde compound or polyoxirane compound, and (ii) a method of chemically reacting the immunologically active material with aldehyde groups or oxirane groups oriented at the surfaces of the solid fine particles. The foregoing dehydrated immune reagent to be used in the present invention can be obtained by removing the dispersing medium used in the dispersed body of the solid fine particles having the immunologically active material thereon. The removal of the dispersing medium is desired to be carried out preferably at 60°C or less, more preferably at 30°C or less in the viewpoint of desirably maintaining the activity of the immunologically active material. In a preferred embodiment of removing the dispersing medium from the dispersed body, the removal of said dispersing medium is performed by way of a freeze-drying method. In this case, the sensitivity of the reagent may be stably maintained in a desirable state. In the case of introducing the dehydrate immune reagent into the measuring cell or the reaction cell, a dispersed body comprising the solid fine particles having the immunologically active material thereon being dispersed in a dispersing medium is introduced into such cell, followed by the foregoing freeze-drying to thereby remove the dispersing medium. In alternative, said dispersed body is freeze-dried to remove the dispersing medium therefrom and the resulting dehydrated immune reagent is introduced into such cell. As the measuring cell or the reaction cell to be used in the present invention, there can be used a conventional sample cell made of a transparent glass such as quartz glass or a transparent plastics such as polystyrene, polymethylmethacrylate, polyvinyl chloride, polycarbonate or polysulfone. As for the dispersing medium to be used for dispersing the dehydrated immune reagent in the measuring cell or the reaction cell in the present invention, there can be mentioned, for example, water and a mixed solvent comprising water and an organic solvent compatible with water such as alcohols, ketones, etc. The dispersing medium may contain a proper pH buffering agent, protein, surface active agent, water-soluble high molecular compound, etc. in case where necessary. In order to prevent the antigen-antibody reaction caused in the immunological measuring method of the present invention from being negatively influenced by the pH value of the solvent used, it is desired to add a pH buffering agent to the reaction system, whereby maintaining the pH value of the reaction system constantly at a predetermined pH value. As such pH buffering agent, there can be used a phosphate buffering agent, Tris-HCl buffering agent, etc. In order to prevent occurrence of a undesirable non-specific reaction in the reaction system, it is effective to add a proper protein to the reaction system. As such protein, there can be used bovine serum albumin, gelatine, etc. In order to further promote dispersion of the dehydrated immune reagent in a dispersing medium, it is effective to add a proper dispersing auxiliary such as surface active agent, water soluble high-molecular compound to the reaction system. As such dispersing auxiliary, there can be used nonionic surface active agent such as TWEEN 20, anionic surface active agent, polyvinyl alcohol, polyacrylamide, polyacrylate, hydroxyethyl cellulose, etc. However, it is necessary to selectively use in a predetermined amount such that the agglutination reaction caused by the combination of an antigen and an antibody is not hindered because of such dispersing auxiliary added. In the present invention, the dehydrated immune reagent is properly diluted by the foregoing dispersing medium depending upon the kind of a material to be measured. That is, as for the solid content of the reaction system, it should be properly determined depending upon the kind of a material to be measured and also depending upon the kind and the size of a measuring cell or a reaction cell to be used. However, in general, it is adjusted to be preferably in the range of 0.01 to 5% by weight, more preferably in the range of 0.05 to 2% by weight. The dispersion of the dehydrated reagent into the dispersing medium can be performed, for example, by a method of injecting a predetermined amount of the dispersing medium into a measuring cell or a reaction cell containing the dehydrated immune reagent, and stirring the contents in said measuring cell or reaction cell by a stirring means or shaking the measuring cell or reaction cell by a shaking means. In the case of stirring the contents in the measuring cell or the reaction cell by a ultrasonic stirring means, there can be afforded a most desirably dispersed body. As for the ultrasonic wave to be employed in this case, it should be selectively used depending upon the kind and the size of a measuring cell or a reaction cell to be used. However, in general, a ultrasonic wave in the range of 15 to 50 Hz in terms of oscillation frequency is used. The dispersed degree of the dehydrated immune reagent dispersed in the dispersing medium in the dispersing step of the immunologically measuring method according to the present invention is observed by an optically measuring means. As such optically measuring means, there can be mentioned a method of measuring the intensity of light transmitted, a method of measuring the intensity of light scattered, and a method of measuring the intensity of light transmitted and the intensity of light scattered in combination. In the case where the foregoing dispersed degree is observed by said method of measuring the intensity of light transmitted, there is provided such a situation as shown in FIG. 3 wherein the quantity of light transmitted through the measuring cell or the reaction cell gradually decreases as the dispersion proceeds and becomes nearly constant when a uniformly dispersed state is provided. The method of determining a desirable dispersed state in the present invention has been established based on the experimental results by the present inventors. This dispersed state determining method comprises confirming if the ratio of an index A obtained by the equation: A = logIo/I versus an index Ao obtained by the equation: Ao = logI′o/I′ satisfies the equation: A/Ao ≦ 1.1, wherein Io and I concern a dispersed body comprising dehydrated immune reagent fine particles dispersed in a dispersing medium obtained in the foregoing step of the first or second embodiment of the immunologically measuring method according to the present inventions, Io is an intensity of incident monochromatic light upon passing through the measuring cell or the reaction cell and I is an intensity of said monochromatic light transmitted or/and scattered at that time, and wherein I′o and I′ concern the reference standard completely dispersed body comprising dehydrated immune reagent fine particles dispersed in a dispersing medium in a measuring or reaction cell, I′o is an intensity of incident monochromatic light upon passing through said cell and I′ is an intensity of said monochromatic light transmitted or/and scattered. The above dispersed state determining method is to explained based on the following experiments in each of the cases of the first and second embodiments of the immunologically measuring method according to the present invention. The First Embodiment Experiment 1-(1) 8 ml of hCG antibody (rabbit) (product by Bio Makor Co., Inc.) was added to 60 ml of 1% suspension of polystyrene latex of 0.3 µm in particle size (product by Japan Snthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The mixture was subjected to sensitization at 40°C for 2 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution added with 1% by weight of bovine serum albumin and 3% by weight of sucrose was added to obtain a hCG sensitized latex suspension of 1% in solid content. A part of the resultant latex suspension was diluted with a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution (hereinafter referred to as "PBS") to obtain a test sample of 0.2% by weight in solid content. This test sample was injected into an optical cell made of quartz glass (light pass lengh: 2mm). Using this, there was obtained a value of the foregoing Ao in accordance with the foregoing method. As a result, the value of the foregoing Ao was 1.27 (measured wave length γ : 633 nm). In addition, the remaining hCG sensitized latex suspension was subjected to freeze-drying under reduced pressure in liquid nitrogen to thereby obtain a dry reagent comprising dehydrated reagent fine particles. This dry reagent was added with a PBS to obtain a mixture of 0.2% by weight in solid content. The test sample was set to a conventional ultrasonic stirring device to perform dispersion of the mixture. During this stirring, a test sample was intermittently taken out, and a part of the test sample was injected into an optical cell made of quartz glass (light path length: 2 mm). In this way, there were obtained four test samples (ExI-1 to ExI-4) respectively being different in the stirring period. For each of these test samples, the value of the foregoing A was obtained in accordance with the foregoing method. And the ratio of A/Ao was obtained. The results obtained were collectively shown in FIG. 6. Then, for the remaining part of each of the four test samples, 0.8 ml thereof was injected into an optical cell made of quartz glass (light path length: 2 mm), 100 µl of a standard hCG solution of 10 IU/ml in concentration was added and stirred in the same manner as in the above case. For each of the resultants, the concentration was measured by a rate assaying method. This measuring procedure was repeated 10 times (that is, n=10) for each case. Based on the measured results, the measuring sensitivity and a variation in the measured values were evaluated for each case. The results obtained in the above were collectively shown in Table 1. Experiment 1-(2) The procedures of Experiment 1-(1) were repeated, except that carboxyl modified polystyrene latex of 0.5 µm in particle size (product by Japan Sythetic Rubber Co., Ltd.) was used in stead of the polystyrene latex and immune globulin G antibody obtained from antihuman CRP goat serum (product by Bio Makor Co., Ltd.) was used instead of the hCG antibody, to thereby observe the dispersed state and evaluate the measuring sensitivity and a variation in the measured values for each of four test samples ExII-1 to ExII-4. The results obtained were collectively shown in FIG. 7 and Table 2. Experiment 1-(3) The procedures of Experiment 1-(1) were repeated, except that instead of the polystyrene latex, there were used styrene-methacrylate copolymer and polymethacrylate respectively with varied particle sizes. Each of the resultant test samples was examined in the same manner as in Experiment 1-(1). The results obtained with respect to the measuring sensitivity were collectively shown in FIG. 8. In FIG. 8, the case in which the evaluated result was good was plotted by the mark "o", the case in which the evaluated result was practically acceptable was plotted by the mark "Δ", and the case in which the evaluated result was practically not acceptable was plotted by the mark "x". In FIG. 8, the evaluated results obtained in the foregoing Experiment 1-(1) and 1-(2) were also plotted in the same way as the above. From the results obtained in Experiments 1-(1) to 1-(3), the present inventors have recognized that when the ratio of A/Ao is beyond the value of 1.1, the measuring sensitivity is not good and the variation in the measured values is large. And the present inventors have found that the ratio of A/Ao=1.1 is the critical value with respect to the measuring sensitivity and the variation in the measured values. Further from the results shown in Tables 1 and 2, the present inventors have found that even if the equation: A/Ao≦1.1 is satisfied, when stirring is continued for a long period of time, there is a tendency that the measuring sensitivity will be reduced, although the variation in the measured values is relatively small. And the present inventors have found a fact that at the time of dispersing dehydrated immune reagent fine particles into a dispersing medium while stirring by a stirring means, when the dispersing process is performed while measuring the dispersed state of the resulting dispersed body, the stirring is terminated when the ratio of A/Ao becomes to lie in the foregoing range and the successive process is conducted, a trace amount of any material to be intended to measure can be measured with a high accuracy. Now, in a preferred embodiment of obtaining the index Ao with respect to a completely dispersed body of dehydrated immune reagent fine particles, the dispersing medium to be used for the preparation of a suspension of a sensitized reagent latex being applied with connection treatment in the way as described in Experiment 1-(1) prior to freeze-drying is made the same as that used for redispersion of dehydrated reagent fine particles and the procedures of obtaining the index Ao are performed, since the physical or chemical connection of an immunologically active material onto solid fine particles is carried out in water or a mixed solvent containing water as the principal component. In the first embodiment of the immunologically measuring method according to the present invention, the dispersed state in the step of dispersing dehydrated reagent fine particles is checked by optical measurement thereof, the resulting measured results are compared with the reference standard optical data of a predetermined dispersed state to decide continuation of the dispersing step, termination of said step or control of the stirring competence. Thus, a highly sensitive dispersed reagent in an uniformly dispersed state is afforded. This dispersed reagent is then mixed and reacted with a specimen. Particularly, a material (to be measured) contained in said specimen which is reactive with the immunologically active material immobilized to the surfaces of the solid fine particles (that is, the immune reagent fine particles) comes in contact with said immunologically active material to cause antigen-antibody reaction resulting in causing agglutination, and said agglutination proceeds depending upon the content of the material to be measured, contained in the specimen. The admixture of the immune reagent fine particles with the specimen containing the material to be measured upon causing said antigen-antibody reaction is performed, for example, by shaking the measuring cell containing said two kinds of materials. In this case, it is important to uniformly and effectively mix said immune reagent fine particles with said specimen, whereby smoothly causing said antigen-antibody reaction in a desirable state which results in causing agglutination reaction in a desirable state. It is also important in this case to properly control the stirring competence by way of shaking not to divide an aggregate resulted by said agglutination reaction. In view of this, the stirring competence in this step is desired to be make rather weak than that in the dispersing step. In order to measure the agglutinated state of the reaction mixture in the measuring cell by irradiating said reaction mixture with light, a method of measuring the intensity of transmitted light, a method of measuring the intensity of scattered light, a combination of these methods or a integrating sphere turbidity measuring method may be selectively employed. The calculation of the content of a material to be measured, contained in a specimen based on the measured data obtained may be conducted by subjecting said measured data to the data processing by a conventional rate assaying method or a conventional end point method. As described above, in a preferred embodiment, the step of dispersing dehydrated immune reagent fine particles into a dispersing medium is performed by an ultrasonic stirring means and the step of mixing and reacting a dispersed body of said immune reagent fine particles with a specimen containing a material to be measured is performed by a shaking means. However, it is possible to employ the latter stirring means in the former step and the former stirring means in the latter step. It is also possible to employ the same stirring means in the both steps. In this case, it is necessary to change its stirring competence depending upon each of the two steps. In the latter case, the stirring means is desired to be equipped with a stirring competence variable means such that the dispersing step can be performed with a strong stirring competence and the mixing and reacting step is performed with a weak stirring competence. For instance, in the case of using the same ultrasonic stirring means in the both steps, it is used an ultrasonic stirring means equipped with an output power variable mechanism. And, although depending upon the constituting material and the volume of a cell to be used, and also upon the effective efficiency thereof, in general, the dispersing step is performed with ultrasonic vibration stirring of 10 to 90 W (20 KHz) in output power and the mixing and reacting step is performed with ultrasonic vibration stirring of 0.1 to 10 W (20 KHz) in output power. The basic principle of the first embodiment of the immunologically measuring method according to the present invention is as shown in the flow chart of FIG. 4. The first embodiment of the immunologically measuring method according to the present invention may be practiced in an appropriate apparatus having the constitution capable of performing said method. In FIG. 1, there is shown a representative apparatus suitable for practicing the first embodiment of the immunologically measuring method according to the present invention. In FIG. 1, numeral reference 2 stands for an optical cell made of acrylic resin or quartz glass which contains dehydrated latex reagent. Numeral reference 12 stands for a bar code of the optical data for dispersing said latex reagent into a dispersing medium which is disposed on the upper exterior of said optical cell 2. The optical cell 2 is placed in a constant temperature vessel 10 which is capable of serving as a holder therefor. The vessel 10 is equipped with a stirring means 11 including an ultrasonic vibrator capable of providing a vibration stirring function and a shaking means capable of providing a shake-stirring function. The optical data of the bar code 12 disposed on the exterior of the optical cell 2 is read by a bar code reading device 13. The optical data read out by the device 13 is transmitted to a data processing device 14, by which the data are memorized. Numeral reference 8 stands for a reservoir containing a dispersing medium. The reservoir 8 is placed in a constant temperature vessel 7. A predetermined amount of the dispersing medium contained in the vessel 7 is introduced through a transporting pipe 19 equipped with a liquid supplying pump 17 into the optical cell 2. The dehydrated latex reagent and the dispersing medium contained in the optical cell 2 placed in the constant temperature vessel 10 are stirred by actuating the ultrasonic vibrator. Numeral reference 1 stands for a light source for radiating light for optical measurement. Numeral reference 6 stands for a half mirror. Beam of light from the light source 1 is supplied into the optical cell 2. As the light source 1 in the case of radiating coherent light, there is used either He-Ne gas laser (wavelength: 632.8 nm) or semiconductor laser (wavelength: 780 nm). Other than these, it is possible use a tungsten lamp or a halogen lamp. In this case, an appropriate wavelength is selected by a monochrometer or a filter. The beam of light supplied into the optical cell 2 is dispersed or absorbed, and light transmitted through the cell is detected by a photomultiplier 3 and light scattered through the cell is detected by a photomultiplier 4. Variation in the light quantity for the light source is detected by a photomultiplier 5, and the signal detected by the photomultiplier 5 is transmitted to the data processing device 14. Likewise, the signal detected by the photomultiplier 3 and the signal detected by the photomultiplier 4 are transmitted to the data processing device 14. These signals transmitted to the data processing device 14 are entered through a A/D conversion circuit into a comparison circuit wherein they are compared with the optical data concerning the dispersion of the latex reagent from a memory circuit. The compared signal is transmitted to a control device 15 for the ultrasonic vibrator in the stirring means 11 to demand termination or continuation of the ultrasonic vibration stirring or to control the competence of the ultrasonic vibration stirring. Upon terminating the stirring step, a specimen containing a material to be measured which is contained in a container 9 is introduced through a transporting pipe 19 equipped with a liquid supplying pump 18 into the optical cell 2. The contents in the optical cell 2 is shake-stirred by actuating the shaking means in the stirring means 11 for a predetermined period of time (for example, for 3 to 5 seconds) and subjected to the optical measurement in the same manner as in the above case. After a predetermined period of time (for example, after a period of 20 seconds to 2 minutes), the same optical measurement is again performed. The signals resulted by the twice optical measurements are transmitted to the data processing device in the same way as in the above case, wherein they are entered through the A/D conversion circuit into a measuring and computing circuit wherein they are computatively processed based on the analytic curve data previously inputted thereinto, to thereby obtain concentration data which are digitally indicated on a display 16. The Second Embodiment Experiment 2-(1) 8 ml of hCG antibody (rabbit) (product by Bio Makor Co., Inc.) was added to 60 ml of 1% suspension of polystyrene latex of 0.71 µm in particle size (product by Japan Snthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The mixture was subjected to sensitization at 40°C for 2 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution added with 1% by weight of bovine serum albumin and 3% by weight of sucrose was added to obtain a hCG sensitized latex suspension of 1% in solid content. A part of the resultant latex suspension was diluted with a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution (hereinafter referred to as "PBS") to obtain a test sample of 0.1% by weight in solid content. This test sample was injected into an optical cell made of quartz glass (light pass lengh: 2mm). Using this, there was obtained a value of the foregoing Ao in accordance with the foregoing method. As a result, the value of the foregoing Ao was 1.71 (measured wavelength γ: 633 nm). In addition, the remaining hCG sensitized latex suspension was subjected to freeze-drying under reduced pressure in liquid nitrogen to thereby obtain a dry reagent comprising dehydrated reagent fine particles. This dry reagent was added with a PBS to obtain a mixture of 0.1% by weight in solid content. The test sample was set to a conventional ultrasonic stirring device to perform dispersion of the mixture. During this stirring, a test sample was intermittently taken out, and a part of the test sample was injected into an optical cell (reaction cell) made of quartz glass (light path length: 2 mm). In this way, there were obtained four test samples (Ex2(1)-1 to Ex2(1)-4) respectively being different in the stirring period. For each of these test samples, the value of the foregoing A was obtained in accordance with the foregoing method. And the ratio of A/Ao was obtained. The results obtained were collectively shown in FIG. 9. Then, for the remaining part of each of the four test samples, 0.5 ml thereof was injected into an optical cell (reaction cell) made of quartz glass (light path length: 2 mm), 100 µl of a standard hCG solution of 10 IU in concentration was added and stirred in the same manner as in the above case, to thereby obtain a reaction mixture. After 60 seconds, the reaction mixture was transferred from the reaction cell into a dilution cell, wherein the reaction mixture was diluted with a PBS to a dilution rate of 1x10 3 . The reaction mixture thus diluted was introduced into a flow cell from the dilution cell while radiating Ar laser, whereby detecting side-scattered light to observe agglutinated states of the reagent fine particles. The results observed were compared with the previously provided analytical curve to thereby measure the concentration of the hCG contained in the specimen. In each case, there was obtained the value of A/Ao and evaluated the measuring sensitivity and a variation in the measured values. The results obtained were as shown in Table 7. Experiment 2-(2) The procedures of Experiment 2-(1) were repeated, except that immune globulin G antibody obtained from antihuman CRP goat serum (product by Bio Makor Co., Ltd.) was used in stead of the hCG antibody, to thereby observe the dispersed state and evaluate the measuring sensitivity and a variation in the measured values for each of four test samples Ex2(2)-1 to Ex2(2)-4. The results obtained were collectively shown in FIG. 10 and Table 8. Experiment 2-(3) The procedures of Experiment 2-(1) were repeated, except that in stead of the polystyrene latex, there were used styrene-methacrylate copolymer and polymethacrylate respectively with varied particle sizes. Each of the resultant test samples was examined in the same manner as in Experiment 2-(1). The results obtained with respect to the measuring sensitivity were collectively shown in FIG. 11. In FIG. 11, the case which the evaluated result was good was plotted by the mark "o", the case which the evaluated result was practically acceptable was plotted by the mark "Δ", and the case which the evaluated result was practically not acceptable was plotted by the mark "x". In FIG. 11. the evaluated results obtained in the foregoing Experiment 2-(1) and 2-(2) were also plotted in the same way as the above. From the results obtained in Experiments 2-(1) to 2-(3), the present inventors have recognized that when the ratio of A/Ao is beyond the value of 1.1, the measuring sensitivity is not good and the variation in the measured values is large. And the present inventors have found that the ratio of A/Ao=1.1 is the critical value with respect to the measuring sensitivity and the variation in the measured values. Further from the results shown in Tables 7 and 8, the present inventors have found that even if the equation: A/Ao ≦1.1 is satisfied, when stirring is continued for a long period of time, there is a tendency that the measuring sensitivity will be reduced, although the variation in the measured values is relatively small. And the present inventors have found the fact that at the time of dispersing dehydrated immune reagent fine particles into a dispersing medium while stirring by a stirring means, when the dispersing process is performed while measuring the dispersed state of the resulting dispersed body, the stirring is terminated when the ratio of A/Ao becomes to lie in the foregoing range and the successive process is conducted, a trace amount of any material to be intended to measure can be measured with a high accuracy. Now, in a preferred embodiment of obtaining the index Ao with respect to a completely dispersed body of dehydrated immune reagent fine particles, the dispersing medium to be used for the preparation of a suspension of a sensitized reagent latex being applied with connection treatment in the way as described in Experiment 2-(1) prior to freeze-drying is made the same as that used for redispersion of dehydrated reagent fine particles and the procedures of obtaining the index Ao are performed, since the physical or chemical connection of an immunologically active material onto solid fine particles is carried out in water or a mixed solvent containing water as the principal component. In the second embodiment of the immunologically measuring method according to the present invention, the dispersed state in the step of dispersing dehydrated reagent fine particles is checked by optical measurement thereof, the resulting measured results are compared with the reference standard optical data of a predetermined dispersed state to decide continuation of the dispersing step, termination of said step or control of the stirring competence. Thus, a highly sensitive dispersed reagent in an uniformly dispersed state is afforded. This dispersed reagent is then mixed and reacted with a specimen. Particularly, a material (to be measured) contained in said specimen which is reactive with the immunologically active material immoblized to the surfaces of the solid fine particles (that is, the immune reagent fine particles) comes in contact with said immunologically active material to cause antigen-antibody reaction resulting in causing agglutination, and said agglutination proceeds depending upon the content of the material to be measured, contained in the specimen. The admixture of the immune reagent fine particles with the specimen containing the material to be measured upon causing said antigen-antibody reaction is performed, for example, by shaking the reaction cell containing said two kinds of materials or by stirring the contents contained in the reaction cell by a stirring means. In this case, it is important to uniformly and effectively mix said immune reagent fine particles with said specimen, whereby smoothly causing said antigen-antibody reaction in a desirable state which results in causing agglutination reaction in a desirable state. It is also important in this case to properly control the stirring competence not to divide an aggregate resulted by said agglutination reaction. In view of this, the stirring competence in this step is desired to be make rather weak than that in the dispersing step. The reaction mixture caused by the antigen-antibody reaction in the reaction cell is in an agglutinated state comprising a plurality of aggregates. The reaction mixture is then transferred into a dilution cell, wherein it is diluted with an appropriate diluent such as PBS, etc. Thereafter, the diluted reaction mixture is sent to a flow cell, when each of the aggregates of the reaction mixture is separately flown such that optical measurement can be performed therefor. In this respect, the dilution of the reaction mixture in the dilution cell is necessary to be adjusted such a degree that allows each of the aggregates of the reaction mixture to separately flow into the flow cell. The foregoing optical measurement is carried out by a conventional flow sight meter of optical axis orthogonal type or identical optical axis type. The calculation of the content of a material to be measured, contained in a specimen is performed based on the data obtained by the optical measurement by referring said data to a reference standard analytical curve previously provided with respect to the interrelation between the material to be measured and the agglutinated state thereof caused by antigen-antibody reaction in a diluted state. As described above, in a preferred embodiment, the step of dispersing dehydrated immune reagent fine particles into a dispersing medium is performed by an ultrasonic stirring means and the step of mixing and reacting a dispersed body of said immune reagent fine particles with a specimen containing a material to be measured is performed by a shaking means. However, it is possible to employ the latter stirring means in the former step and the former stirring means in the latter step. It is also possible to employ the same stirring means in the both steps. In this case, it is necessary to change its stirring competence depending upon each of the two steps. In the latter case, the stirring means is desired to be equipped with a stirring competence variable means such that the dispersing step can be performed with a strong stirring competence and the mixing and reacting step is performed with a weak stirring competence. For instance, in the case of using the same ultrasonic stirring means in the both steps, it is used an ultrasonic stirring means equipped with an output power variable mechanism. And, although depending upon the constituting material and the volume of a cell to be used, and also upon the effective efficiency thereof, in general, the dispersing step is performed with ultrasonic vibration stirring of 10 to 90 W (20 KHz) in output power and the mixing and reacting step is performed with ultrasonic vibration stirring of 0.1 to 10 W (20 KHz) in output power. The basic principle of the second embodiment of the immunologically measuring method according to the present invention is as shown in the flow chart of FIG. 5. The second embodiment of the immunologically measuring method according to the present invention may be practiced in an appropriate having the constitution capable of performing said method. In FIG. 2, there is shown a representative apparatus suitable for practicing the second embodiment of the immunologically measuring method according to the present invention. In FIG. 2, numeral reference 2 stands for an optical cell (reaction cell) made of acrylic resin or quartz glass which contains dehydrated latex reagent. Numeral reference 12 stands for a bar code which is disposed on the upper exterior of the reaction cell 2. The bar code 12 contains a code concerning the optical data for dispersing said latex reagent into a dispersing medium and a code for calling data of the reference standard analytic curve from a memory circuit. The reaction cell 2 is placed in a constant temperature vessel 10 which is capable of serving as a holder therefor. The vessel 10 is equipped with a stirring means 11 including an ultrasonic vibrator capable of providing a vibration stirring function and a shaking means capable of providing a shake-stirring function. The data of the bar code 12 disposed on the exterior of the optical cell 2 is read by a bar code reading device 13. The data read out by the device 13 is transmitted to a data processing device 14, by which the data are memorized. Numeral reference 8 stands for a reservoir containing a dispersing medium. The reservoir 8 is placed in a constant temperature vessel 7. A predetermined amount of the dispersing medium contained in the vessel 7 is introduced through a transporting pipe 29 equipped with a liquid supplying pump 17 into the reaction cell 2. The dehydrated latex reagent and the dispersing medium contained in the reaction cell 2 placed in the constant temperature vessel. 10 are stirred by actuating the ultrasonic vibrator. Numeral reference 1 stands for a light source for radiating light for optical measurement. Numeral reference 6 stands for a half mirror. Beam of light from the light source 1 is supplied into the reaction cell 2. As the light source 1 in the case of radiating coherent light, there is used either He-Ne gas laser (wavelength: 632.8 nm) or semiconductor laser (wavelength: 780 nm or 830 nm). Other than these, it is possible use a tungsten lamp or a halogen lamp. In this case, an appropriate wavelength is selected by a monochrometer or a filter. The beam of light supplied into the reaction cell 2 is dispersed or absorbed, and light transmitted through the cell is detected by a photomultiplier 3 and light scattered through the cell is detected by a photomultiplier 4. Variation in the light quantity for the light source 1 is detected by a photomultiplier 5, and the signal detected by the photomultiplier 5 is transmitted to the data processing device 14. Likewise, the signal detected by the photomultiplier 3 and the signal detected by the photomultiplier 4 are transmitted to the data processing device 14. These signals transmitted to the data processing device 14 are entered through a A/D conversion circuit into a comparison circuit wherein they are compared with the optical data concerning the dispersion of the latex reagent from a memory circuit. The compared signal is transmitted to a control device 15 for the ultrasonic vibrator in the stirring means 11 to demand termination or continuation of the ultrasonic vibration stirring or to control the competence of the ultrasonic vibration stirring. Upon terminating the stirring step, a specimen containing a material to be measured which is contained in a container 9 is introduced through a transporting pipe 29 equipped with a liquid supplying pump 18 into the reaction cell 2. The contents in the reaction cell 2 is shake-stirred by actuating the shaking means in the stirring means 11 for a predetermined period of time (for example, for 3 to 5 seconds) to cause agglutination reaction. The reaction mixture caused in the reaction cell is sent to a dilution cell 20 placed in a constant temperature vessel 10 through a transporting pipe 29 equipped with a liquid supplying pump 19, in accordance with the conditions under which the foregoing reference standard analytic curve. At the same time, a predetermined amount of a diluent contained in a reservoir 22 placed in a constant temperature vessel 21 is supplied into the dilution cell 20 through a transporting pipe 29 equipped with a liquid supplying pump 23. The reaction mixture and the diluent thus introduced into the dilution cell 20 are uniformly mixed by stirring them by a stirring means 24. Thus, the reaction mixture is diluted to a predetermined dilution degree. The admixture of the reaction mixture with the diluent in the dilution cell 20 may be performed by stirring them using the foregoing ultrasonic vibration stirring means or shake-stirring means. In this case, such stirring means is provided to the constant temperature vessel 10 (not shown). The reaction mixture thus diluted in the dilution cell is sent a flow cell 26 through a transporting pipe 29 equipped with liquid supplying pump 25. In this case, the diluted reaction mixture is flown such that each of the aggregates of the reaction mixture individually passes through the flow cell 26 and side-scattered light caused by radiating laser beam from a laser beam source when each of the aggregates passes through the flow cell 26 can be detected by a photomultiplier 28. The signals detected by the photomultiplier are transmitted to the data processing device 14, wherein they are entered through the A/D conversion circuit into a measuring and computing circuit wherein they are computatively processed based on the analytic curve data previously inputted thereinto, to thereby obtain concentration data which are digitally indicated on a display 16. DESCRIPTION OF THE PREFERRED EMBODIMENTS The immunologically measuring method of the present invention will be described in more detail with reference to the following examples, which are not intended to restrict the scope of the present invention. In the following, Examples 1-(1) to 1-(5) are of the first embodiment and Examples 2-(1) to 2-(4) are of the second embodiment. Example 1-(1) - Measurement of hCG - In this example, there was used the apparatus shown in FIG. 1. Preparation of an antibody sensitized latex suspension: 8 ml of hCG antibody (rabbit)(product by Bio Makor Co., Ltd.) was added to 60 ml of 1% suspension of polystyrene latex of 0.3 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The mixture was subjected to sensitization at 40°C for 2 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution (hereinafter referred to as "PBS") added with 1% by weight of bovine serum albumin and 3% by weight of sucrose was added to obtain a hCG antibody sensitized latex suspension of 1% by weight in solid content. Dehydration of the reagent: The hCG antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain dehydrated reagent fine particles (hereinafter referred to as "dry reagent (A)"). Measurement and Evaluation: (1) There was provided an optical cell made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (A). PBS was introduced into the optical cell to obtain a mixture of 0.2% by weight in reagent solid content. The optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the exponential A of the foregoing equation: A=IogIo/I was tried to obtain (measuring wave length: 633 mm). (2) Separately, the foregoing hCG antibody sensitized latex suspension was added with PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell of the same kind in the above. The optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=IogI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 1.27 for the index Ao. The ultrasonic vibration stirring treatment in the above (1) was terminated when the exponential A satisfied the equation: A/Ao≧ 1.1 (The stirring period: 160 seconds). 100 µl of a standard hCG solution which was adjusted to be 10 IU/ml was introduced into the optical cell, which was followed by shake-stirring treatment for 3 seconds. The absorbance of the resultant was measured at the time after 20 seconds and at the time after 200 seconds in order to observe a variation (ΔA) in the values measured (with light of 633 nm in wavelength). In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. And the coefficient of variation (C.V.) was also observed. The results obtained were as shown in Table 3. Separately, in order to observe a variation among a plurality of dehydrated latex reagents which were separately prepared, there were provided three dehydrated latex reagent samples A, B and C which were separately prepared. The above procedures were performed for each sample. The observed results for each of these three samples were as shown in Table 4. Comparative Example 1-(1) The procedures of Example 1-(1) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time. The observed results were as shown Tables 3 and 4. Evaluation of the results in Example 1-(1) and Comparative Example 1-(1) In Table 3, there are shown the results of the coincident reproducibility test against hCG which were obtained in Example 1-(1) and Comparative Example 1-(1). In Table 4, there are shown the results of the coincident reproducibility test against hCG with respect to separately prepared latex reagents which were obtained in Example 1-(1) and Comparative Example 1-(1). From the results shown in Table 3, it is understood that Example 1-(1) wherein the stirring period of the latex reagent was made changeable is surpassing Comparative Example 1-(1) wherein the stirring period was fixed to 200 seconds or 300 seconds in the viewpoints that the variation of data obtained in the former is distinguishably small in comparison with that in the latter and the stirring period can be markedly shortened in the former. It is also understood that in the case of Comparative Example 1-(1), the change in the absorbance (ΔA) decreases and the measuring sensitivity reduces as the stirring period prolongs. From the results shown in Table 4, it is understood that in the case of Example 1-(1), there is not a distinguishable difference with respect to data obtained among the separately prepared latex reagents but in the case of Comparative Example 1-(1), there is a distinguishable difference with respect to data obtained among the separately prepared latex reagents. Example 1-(2) - Measurement of CRP - In this example, there was used the apparatus shown in FIG. 1. Preparation of an antibody sensitized latex suspension: Antihuman CRP goat serum (product by Bio Makor Co., Ltd.) was subjected to column treatment to extract an antibody comprising immune globulin G. 4 ml of the antibody thus extracted was mixed with 60 ml of 1% suspension of polystyrene latex of 0.5 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The resultant was subjected to sensitization at 45°C for 2 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture composed of 0.02 M phosphate buffering solution, 1% by weight of bovine serum albumin and 5% by weight of sucrose was added in an amount to provide a suspension of 1% by weight in solid content. Thus, there was prepared a CRP antibody sensitized latex suspension. Dehydration of the reagent: The antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain a dry reagent comprising dehydrated reagent fine particles (hereinafter referred to as "dry reagent (B)"). Measurement and Evaluation: (1) The foregoing CRP antibody sensitized latex suspension was added with PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass (light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 1.39 for the index Ao. (2) There was provided a CRP serum solution of 0.5 mg/dl in concentration which was prepared by diluting a standard CRP serum (product by Kyowayuka Kabushiki Kaisha) with Tris HCl buffering solution. There was also provided an optical cell made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (B). PBS was introduced into the optical cell to prepare a mixture of 0.2% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=IogIo/I was observed. When the index A came to satisfy the equation: A/Ao ≦ 1.1 (the stirring period: 190 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 20 µl of the foregoing CRP serum solution was introduced into the above optical cell, which was followed by shake-stirring treatment for 3 seconds. The absorbance of the resultant was measured at the time after 20 seconds and at the time after 200 seconds in order to observe a variation (ΔA) in the values measured (with light of 633 nm in wavelength). In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. And the coefficient of variation (C.V.) was also observed. The results obtained were as shown in Table 5. Comparative Example 1-(2) The procedures of Example 1-(2) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time (100 seconds or 200 seconds). The results obtained were as shown in Table 5. Example 1-(3) - Measurement of β 2 -microglobulin In this example, there was used the apparatus shown in FIG. 1. Preparation of an antibody sensitized latex suspension: 6 ml of antihuman β 2 -microglobulin (rabbit)(product by Bio Makor Co., Ltd.) was mixed with 60 ml of 1% suspension of polystyrene latex of 0.5 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The resultant was subjected to sensitization at 47°C for 2 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a PBS of 7.2 in pH value added with 1% by weight of bovine serum albumin and 5% by weight of sucrose was added in an amount to provide a suspension of 1% by weight in solid content. Thus, there was prepared a β 2 -microglobulin antibody sensitized latex suspension. Dehydration of the reagent: The antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain a dry reagent comprising dehydrated reagent fine particles (hereinafter referred to as "dry reagent (C)"). Measurement and Evaluation: (1) The foregoing β 2 -microglobulin antibody sensitized latex suspension was added with a PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass (light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 1.34 for the index Ao. (2) There was provided a β 2 -microglobulin serum solution of 5 µg/ml in concentration which was prepared by diluting a standard β 2 -microglobulin serum (product by Kyowayuka Kabushiki Kaisha) with Tris HCl buffering solution. There was also provided an optical cell made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (C). PBS was introduced into the optical cell to prepare a mixture of 0.2% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=IogIo/I was observed. When the index A came to satisfy the equation: A/Ao≦ 1.1 (the stirring period: 145 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 20 µl of the foregoing β 2 -microglobulin serum solution was introduced into the above optical cell, which was followed by shake-stirring treatment for 3 seconds. The absorbance of the resultant was measured at the time after 20 seconds and at the time after 200 seconds in order to observe a variation (ΔA) in the values measured (with light of 633 nm in wavelength). In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. And the coefficient of variation (C.V.) was also observed. The results obtained were as shown in Table 5. Comparative Example 1-(3) The procedures of Example 1-(3) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time (100 seconds or 200 seconds). The results obtained were as shown in Table 5. Example 1-(4) - Measurement of AFP - In this example, there was used the apparatus shown in FIG. 1. Preparation of an antibody sensitized latex suspension: Antihuman α-fetoprotein (horse) (AFP) serum (product by Midorijuji Kabushiki Kaisha) was subjected to column treatment to extract an antibody comprising immune globulin G. 1.5 ml of the antibody thus extracted was mixed with 15 ml of 1% suspension of polystyrene latex of 0.5 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The resultant was subjected to sensitization at 40°C for 3 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture composed of 0.02 M phosphate buffering solution, 1% by weight of bovine serum albumin and 5% by weight of sucrose was added in an. amount to provide a suspension of 1% by weight in solid content. Thus, there was prepared a AFP antibody sensitized latex suspension. Dehydration of the reagent: The antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain a dry reagent comprising dehydrated reagent fine particles (hereinafter referred to as "dry reagent (D)"). Measurement and Evaluation: (1) The foregoing AFP antibody sensitized latex suspension was added with a PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass (light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 1.30 for the index Ao. (2) There was provided a AFP serum solution of 150 ng/ml in concentration which was prepared by diluting a standard AFP serum (product by Kyowayuka Kabushiki Kaisha) with Tris HCl buffering solution. There was also provided an optical cell made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (D). PBS was introduced into the optical cell to prepare a mixture of 0.2% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=IogIo/I was observed. When the index A came to satisfy the equation: A/Ao≦1.1 (the stirring period: 190 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 20 µl of the foregoing AFP serum solution was introduced into the above optical cell, which was followed by shake-stirring treatment for 3 seconds. The absorbance of the resultant was measured at the time after 20 seconds and at the time after 200 seconds in order to observe a variation (ΔA) in the values measured (with light of 633 nm in wavelength). In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. And the coefficient of variation (C.V.) was also observed. The results obtained were as shown in Table 5. Comparative Example 1-(4) The procedures of Example 1-(4) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time (100 seconds or 200 seconds). The results obtained were as shown in Table 5. Evaluation of the results in Examples 1-(2) to (4) and Comparative Examples 1-(2) to (4) Table 5 illustrates the measured results with respect to the coincident reproducibility against CRP, β 2 -microglobulin, or AFP in Examples 1-(2) to (4) and Comparative Examples 1-(2) to (4). From the results shown in Table 5, it is understood that any case of Examples 1-(2) to (4) wherein the stirring period of the latex reagent was made changeable is surpassing any case of Comparative Examples 1-(2) to (4) in the viewpoints that the variation of data obtained in the former is distinguishably small in comparison with that in the latter and the stirring period can be markedly shortened in the former. Example 1-(5) - Measurement of hCG - In this example, there was used the apparatus shown in FIG. 1. Preparation of an antibody sensitized latex suspension: 8 ml of hCG antibody (rabbit)(product by Bio Makor Co., Ltd.) was added to 60 ml of 1% suspension of polystyrene latex of 0.3 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The mixture was subjected to sensitization at 40°C for 2 hours. The resultant sensitized latex was subjected to contrifugal washing. To the sensitized latex thus washed, a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution (that is, PBS) added with 1% by weight of bovine serum albumin and 3% by weight of sucrose was added to obtain a hCG antibody sensitized latex suspension of 1% by weight in solid content. Dehydration of the reagent: The hCG antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain dehydrated reagent fine particles (hereinafter referred to as "dry reagent (E)"). Measurement and Evaluation: (1) The foregoing hCG antibody sensitized latex suspension was added with PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass (light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment at an output power of 15 W (20 kHz) in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 1.25 for the index Ao. (2) There was provided a hCG solution which was prepared by diluting a standard hCG (product by Japan Chemical Research Co., Ltd.) with a PBS to 10 IU/ml. There was also provided an optical cell made of quartz glass (light pass length: 2mm) charged with 1.2 mg of the dry reagent (E). PBS was introduced into the optical cell to prepar a mixture of 0.2% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment at an output power of 15 W (20 kHz) in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=logIo/I was observed (with light of 633 nm in wavelength). When the index A came to satisfy the equation: A/Ao≦1.1 (the stirring period: 160 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 100 µl of the foregoing hCG solution was introduced into the above optical cell, which was followed by ultrasonic vibration stirring treatment at an output power of 2 W (20 kHz) for 3 seconds. The absorbance of the resultant was measured at the time after 20 seconds and at the time after 200 seconds in order to observe a variation (ΔA) in the values measured. In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. The results obtained were as shown in Table 6. Example 2-(1) - Measurement of hCG - In this example, there was used the apparatus shown in FIG. 2. Preparation of an antibody sensitized latex suspension: 8 ml of a hCG antibody (rabbit)(product by Bio Makor Co., Ltd.) was added to 60 ml of 1% suspension of polystyrene latex of 0.71 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The mixture was subjected to sensitization at 40°C for 2 hours. The resultant sensitized latex was subjected to contrifugal washing. To the sensitized latex thus washed, a mixture of 7.2 in pH value composed of phosphate buffering solution and physiological salt solution (hereinafter referred to as "PBS") added with 1% by weight of bovine serum albumin and 5% by weight of sucrose was added to obtain a hCG antibody sensitized latex suspension of 1% by weight in solid content. Dehydration of the reagent: The hCG antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain dehydrated reagent fine particles (hereinafter referred to as "dry reagent (F)"). Measurement and Evaluation: (1) The foregoing hCG antibody sensitized latex suspension was added with PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass (reaction cell, light pass length: 2 mm). The optical reaction cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 780 nm in wavelength). As a result, there was obtained a value of 1.71 for the index Ao. (2) There was provided a hCG solution which was prepared by diluting a standard hCG (product by Japan Chemical Research Co., Ltd.) with PBS to 10 IU/ml. There was also provided an optical cell made of quartz glass (reaction cell, light pass length: 2 mm) charged with 1.2 mg of the dry reagent (F). PBS was introduced into the optical cell (reaction cell) to prepare a mixture of 0.2% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=logIo/I was observed. When the index A came to satisfy the equation: A/Ao≦1.1 (the stirring period: 55 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 100 µl of the foregoing hCG solution was introduced into the above optical cell, which was followed by stirring treatment by the shake-stirring means for 3 seconds to obtain a reaction mixture. After 60 seconds, the reaction mixture was transferred from the reaction cell into a dilution cell, wherein the reaction mixture was diluted with a PBS to a dilution rate of 1x10 3 . The reaction mixture thus diluted was introduced into a flow cell from the dilution cell while radiating Ar laser (488 nm), whereby detecting side-scattered light to observe agglutinated states of the reagent fine particles. The results observed were compared with the previously provided analytical curve to thereby measure the concentration of the hCG contained in the specimen. In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. The results obtained were as shown in Table 9. Comparative Example 2-(1) The procedures of Example 2-(1) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time. The results obtained were as shown in Table 9. Evaluation of the results in 2-(1) and Comparative Example 2-(1) From the results shown in Table 9, the following facts have been found. That is, (1) when the dispersed state of the reagent is continuously checked and the stirring is terminated when the dispersed state of the reagent becomes to satisfy the specific requirement, there is obtained a measured value almost equivalent the real content of an immunologically active material (hCG) to be measured, contained in a specimen and there is provided an excellent coincident reproducibility; (2) when the stirring period is fixed to a relatively short period of time (for 30 seconds or 60 seconds), there is caused agglutination of fine particles prior to antigen-antibody reaction resulting in causing agglutination reaction, whereby making it impossible to provide a desirable dispersed state of the reagent, and because of this, the situation makes it impossible to obtain an accurate measured value and the coincident reproducibility becomes worse; (3) when the stirring period is fixed to a relatively long period of time (300 seconds), there is afforded a desirable dispersed state of the reagent, but the measuring sensitivity is markedly reduce because of deactivation of the reagent and there cannot be afforded an accurate measured value. Example 2-(2) - Measurement of CRP - In this example, there was used the apparatus shown in FIG. 2. Preparation of an antibody sensitized latex suspension: Antihuman CRP goat serum (product by Bio Makor Co., Ltd.) was subjected to column treatment to extract an antibody comprising immune globulin G. 4 ml of the antibody thus extracted was mixed with 60 ml of 1% suspension of polystyrene latex of 0.71 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The resultant was subjected to sensitization at 45°C for 2 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture composed of 0.02 M phosphate buffering solution, 1% by weight of bovine serum albumin and 5% by weight of sucrose was added in an amount to provide a suspension of 1% by weight in solid content. Thus, there was prepared a CRP antibody sensitized latex suspension. Dehydration of the reagent: The antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain a dry reagent comprising dehydrated reagent fine particles (hereinafter referred to as "dry reagent (G)"). Measurement and Evaluation: (1) The foregoing CRP antibody sensitized latex suspension was added with PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass (light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 1.65 for the index Ao. (2) There was provided a CRP serum solution of 0.5 mg/dl in concentration which was prepared by diluting a standard CRP serum (product by Kyowayuka Kabushiki Kaisha) with Tris HCl buffering solution. There was also provided an optical cell (reaction cell) made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (G). PBS was introduced into the optical cell to prepare a mixture of 0.1% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=IogIo/I was observed (with light of 633 nm in wavelength). When the index A came to satisfy the equation: A/Ao≦1.1 (the stirring period: 45 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 20 µl of the foregoing CRP serum solution was introduced into the above optical cell, which was followed by shake-stirring treatment for 3 seconds to obtain a reaction mixture. After 120 seconds, the reaction mixture was transferred from the reaction cell into a dilution cell, wherein the reaction mixture was diluted with a PBS to a dilution rate of 1x10 3 . The reaction mixture thus diluted was introduced into a flow cell from the dilution cell while radiating Ar laser (488 nm), whereby detecting side-scattered light to observe agglutinated states of the reagent fine particles. The results observed were compared with the previously provided analytical curve to thereby measure the concentration of the CRP contained in the specimen. In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. The results obtained were as shown in Table 10. Comparative Example 2-(2) The procedures of Example 2-(2) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time (48 seconds). The results obtained were as shown in Table 10. Example 2-(3) - Measurement of β 2 -microglobulin In this example, there was used the apparatus shown in Fig. 2. Preparation of an antibody sensitized latex suspension: 6 ml of antihuman β 2 -microglobulin (rabbit) (product by Bio Makor Co., Ltd.) was mixed with 60 ml of 1% suspension of polystyrene latex of 0.71 um in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The resultant was subjected to sensitization at 47°C for 3 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a PBS of 7.2 in pH value added with 1% by weight of bovine serum albumin and 5% by weight of sucrose was added in an amount to provide a suspension of 1% by weight in solid content. Thus, there was prepared a β 2 -microglobuline antibody sensitized latex suspension. Dehydration of the reagent: The antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain a dry reagent comprising dehydrated reagent fine particles (hereinafter referred to as "dry reagent (H)"). Measurement and Evaluation: (1) The foregoing β 2 -microglobulin antibody sensitized latex suspension was added with a PBS to obtain a suspension of 0.2% by weight in reagent solid content in an optical cell made of quartz glass(light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed (with light of 633 nm in wavelength). As a result, there was obtained a value of 2.20 for the index Ao. (2) There was provided a β 2 -microglobulin serum solution of 0.5 mg/dl in concentration which was prepared by diluting a standard β 2 -microglobulin serum (product by Kyowayuka Kabushiki Kaisha) with Tris HCl buffering solution. There was also provided an optical cell (reaction cell) made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (H). PBS was introduced into the optical cell to prepare a mixture of 0.2% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=logIo/I was observed with light of 633 nm in wavelength. When the index A came to satisfy the equation: A/Ao ≦ 1.1 (the stirring period: 65 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 20 µl of the foregoing β 2 -microglobulin serum solution was introduced into the above optical cell, which was followed by shake-stirring treatment for 3 seconds to obtain a reaction mixture. After 120 seconds, the reaction mixture was transferred from the reaction cell into a dilution cell, wherein the reaction mixture was diluted with a PBS to a dilution rate of 1x10 3 . The reaction mixture thus diluted was introduced into a flow cell from the dilution cell while radiating Ar laser (488 nm), whereby detecting side-scattered light to observe agglutinated states of the reagent fine particles. The results observed were compared with the previously provided analytical curve to thereby measure the concentration of the β 2 -microglobulin contained in the specimen. In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. The results obtained were as shown in Table 10. Comparative Example 2-(3) The procedures of Example 2-(3) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time (62 seconds). The results obtained were as shown in Table 10. Example 2-(4) - Measurement of AFP - In this example, there was used the apparatus shown in FIG. 2. Preparation of an antibody sensitized latex suspension: Antihuman α-fetoprotein (horse) (AFP) serum (product by Midorijuji Kabushiki Kaisha) was subjected to column treatment to extract an antibody comprising immune globulin G. 1.5 ml of the antibody thus extracted was mixed with 15 ml of 1% suspension of polystyrene latex of 0.71 µm in particle size (product by Japan Synthetic Rubber Co., Ltd.) and well mixed to obtain a mixture. The resultant was subjected to sensitization at 40°C for 3 hours. The resultant sensitized latex was subjected to centrifugal washing. To the sensitized latex thus washed, a mixture composed of 0.02 M phosphate buffering solution, 1% by weight of bovine serum albumin and 5% by weight of sucrose was added in an amount to provide a suspension of 1% by weight in solid content. Thus, there was prepared a AFP antibody sensitized latex suspension. Dehydration of the reagent: The antibody sensitized latex suspension obtained in the above was subjected to freeze-drying under reduced pressure in liquid nitrogen to obtain a dry reagent comprising dehydrated reagent fine particles (hereinafter referred to as "dry reagent (I)"). Measurement and Evaluation: (1) The foregoing AFP antibody sensitized latex suspension was added with a PBS to obtain a suspension of 0.1% by weight in reagent solid content in an optical cell made of quartz glass (light pass length: 2 mm). The suspension in the optical cell was subjected to ultrasonic vibration stirring treatment in order to obtain a dispersed body. During this step, the index Ao of the foregoing equation: Ao=logI′o/I′ was observed with light of 633 nm in wavelength. As a result, there was obtained a value of 1.70 for the index Ao. (2) There was provided a AFP serum solution of 150 ng/ml in concentration which was prepared by diluting a standard AFP serum (product by Kyowayuka Kabushiki Kaisha) with Tris HCl buffering solution. There was also provided an optical cell (reaction cell) made of quartz glass (light pass length: 2 mm) charged with 1.2 mg of the dry reagent (I). PBS was introduced into the optical cell to prepare a mixture of 0.1% by weight in solid content therein. The mixture in the optical cell was subjected to vibration stirring treatment in order to obtain a dispersed body. During this dispersing step, the index A of the foregoing equation: A=logIo/I was observed with light of 633 nm in wavelength. When the index A came to satisfy the equation: A/Ao≦1.1 (the stirring period: 47 seconds), the ultrasonic vibration stirring treatment was terminated. Then, 20 µl of the foregoing AFP serum solution was introduced into the above optical cell, which was followed by shake-stirring treatment for 3 seconds to obtain a reaction mixture. After 120 seconds, the reaction mixture was transferred from the reaction cell into a dilution cell, wherein the reaction mixture was diluted with a PBS to a dilution rate of 1x10 3 . The reaction mixture thus diluted was introduced into a flow cell from the dilution cell while radiating Ar laser (488 nm), whereby detecting side-scattered light to observe agglutinated states of the reagent fine particles. The results observed were compared with the previously provided analytical curve to thereby measure the concentration of the AFP contained in the specimen. In order to observe the coincident reproducibility, the above procedures were repeated ten times in total. The results obtained were as shown in Table 10. Comparative Example 2-(4) The procedures of Example 2-(4) were repeated, except that the ultrasonic vibration stirring period was made constant at a fixed period of time (44 seconds). The results obtained were as shown in Table 10. Evaluation of the results in Examples 2-(2) to (4) and Comparative Examples 2-(2) to (4) Table 10 illustrates the measured results with respect to the coincident reproducibility against CRP, β 2 -microglobulin, or AFP in Examples 2-(2) to (4) and Comparative Examples 2-(2) to (4). From the results shown in Table 5, it is understood that any case of Examples 2-(2) to (4) wherein the stirring period of the latex reagent was made changeable is surpassing any case of Comparative Examples 2-(2) to (4) in the viewpoints that the variation of data obtained in the former is distinguishably small in comparison with that in the latter and the stirring period can be markedly shortened in the former. Sample No. Dispersed stale (A/A o ) Measuring Sensitivity Variation of a measured value (n = 10) Ex I- 1 1.35 × large - 2 1.13 Δ middle - 3 1.08 ○ small - 4 1.07 Δ small Note: ○ : Good, Δ : Practically acceptable, × : Practically not acceptable Sample No. Dispersed stale (A/A o ) Measuring Sensitivity Variation of a measured value (n = 10) Ex II- 1 1.40 × large - 2 1.12 Δ middle - 3 1.09 ○ small - 4 1.05 Δ ~ × small Note: ○ : Good, Δ : Practically acceptable , × : practically not acceptable CONCURRENT REPRODUCIBUTY TEST (same reagent lot) Example 1-(1) Comparative Example 1-(1) Stirring Period varied (90 to 210 sec.) 140 sec. on average 100 sec. (fixed) 200 sec. (fixed) 300 sec. (fixed) Measured cycle times (N) 10 10 10 10 Mean value Δ A (x) 0.230 0.239 0.210 0.181 Standerd Deviation (S.D.) 4.4 × 10 -3 1.2 × 20 -2 6.5 × 10 -2 4.9 × 10 -3 Coefficient of variation (C.V.%) 1.9 5.2 3.1 2.7 CONCURENT REPROPUCIBUTY TEST Material to be measured Stirring Period Coefficient of Variation (C.V.%) CRP Example 1-(2) varied (80 to 220 sec.) 4.1 150 sec. on average Comparative Example 1-(2) (fixed) 100 sec. 7.9 (fixed) 200 sec. 5.1 β 2 microglobulin Example 1-(3) varied (40 to 200 sec.) 5.0 125 sec. on average Comparative Example 1-(3) (fixed) 100 sec. 9.4 (fixed) 200 sec. 5.3 AFP Example 1-(4) varied (90 to 250 sec.) 3.9 165 sec. on average Comparative Example 1-(4) (fixed) 100 sec. 8.3 (fixed) 200 sec. 5.2 CONCURRENT REPRODUCIBUTY TEST Example 1-(5) Stirring Period varied (90 to 180 sec.) 130 sec. on average Measured cycle (N) 10 Mean value ΔA(x) 0.291 Standerd Reviation (S.D.) 4.9 × 10 -3 Cofficient of variation (C.V.%) 1.7 Sample No. Dispersed state (A/A o ) Measuring Sensitivity Variation of a measured value Ex 2(1)- 1 1.54 × large - 2 1.17 Δ middle - 3 1.09 ○ small - 4 1.06 × small Note: ○ : Good, Δ : Practically acceptable , × : Practically not acceptable Sample No. Dispersed state (A/A o ) Measuring Sensitivity Variation of a measured value Ex 2(2)- 1 1.50 × large - 2 1.13 Δ middle - 3 1.09 ○ small - 4 1.06 × small Note: ○ : Good, Δ : Practically acceptable , × : Practically not acceptable Example 2-(1) Comparative Example 2-(1) Stirring Period 57 to 70 sec. sec. sec. sec. (65 sec. on average) 30 60 300 Measured cycle times 10 10 10 10 A/Ao (average) 1.09 1.52 1.18 1.06 A/Ao varied (Standerd Deviation) 0.01 0.23 0.10 0.01 hCG content ( x ) 9.87 IU/mℓ 14.53 11.62 6.30 x variation (Standerd Deviation (S.D.) 0.70 2.80 1.39 0.32 Coefficient of variation (C.V.%) 7.1 19.3 12.0 5.1 Material to be measured Stirring Period Coefficient of Variation (CV) CRP Example 2-(2) 40 to 59 sec. 4.5 (48 sec. on average) Comparative Example 2-(2) 48 sec. (fixed) 9.8 β 2 - microglobulin Example 2-(3) 55 to 75 sec. 4.0 (62 sec. on average) Comparative Example 2-(3) 62 sec. (fixed) 12.0 AFP Example 2-(4) 38 to 50 sec. 5.8 (44 sec. on average) Comparative Example 2-(4) 44 sec. (fixed) 14.5 There are provided a method and an apparatus for measuring an immunologically active material by physically or chemically immobilizing a material being immunologically active to a material to be measured of a specimen onto dehydrated solid fine particles, providing a desired dispersed body of said immunologically active material immobilized onto said solid fine particles in a dispersing medium, adding the specimen to said dispersed body while stirring to react the specimen with the immologically active material, whereby causing a reaction mixture in an agglutinated state and optically measuring said agglutinated state of the reaction mixture to thereby quantitatively determine the content of the material to be measured with an improved accuracy.

Claims: A method for measuring an immunologically active material by physically or chemically immobilizing a material immunologically active to a material to be measured of a specimen to solid fine particles, reacting said immunologically active material immobilized on said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state and optically measuring said agglutinated state of the reaction mixture, characterized by including the steps of: (i) introducing a dispersing medium into a measuring cell containing dehydrated solid fine particles having a material immunologically active to a material to be measured of a specimen, being physically or chemically immobilized on the surfaces of said fine particles (these dehydrated solid fine particles will be hereinafter referred to as "dry reagent fine particles"); (ii) stirring said dispersing medium and said dry reagent fine particles while optically measuring the state of said dry reagent fine particles being dispersed in said dispersing medium, (iii) observing the dispersed state of said dry reagent fine particles in said dispersing medium on the basis of the optically measured results obtained in the step (ii) and terminating the stirring of the step (ii) when a predetermined dispersed state is provided, (iv) adding said specimen to the dispersed body in the predetermined dispersed state, mixing and reacting them to cause a reaction mixture in an agglutinated state, and (v) optically measuring the agglutinated state of the reaction mixture, wherein the step (iii) of observing the dispersed state of the dry reagent line particles in the dispersing medium is performed by confirming if the ratio of an index A obtained by the equation (1): A=logIo/I versus an index Ao obtained by the equation (2): Ao=logI'o/I' satisfies the equation: A/Ao≦1.1, wherein the equation (1) is of the dry reagent particles dispersed body obtained in the step (ii), Io is an intensity of incident monochromatic light upon passing through the measuring cell containing said dispersed body and I is an intensity of light transmitted or scattered at that time, and wherein the equation (2) is of the reference standard dry reagent particles dispersed body, I'o is an intensity of incident monochromatic light upon passing through the measuring cell containing said standard dispersed body and I' is an intensity of light transmitted or scattered at that time. The method according to claim wherein the material to be measured is HCG. The method according to claim 1, wherein the material to be measured is CRP. The method according to claim 1, wherein the material to be measured is β 2 -microglobulin. The method according to claim 1, wherein the material to be measured is α-fetoprotein. An apparatus for performing the method according to any of the claims 1 to 5, comprising means for supporting said measuring cell containing said solid fine particles, means for injecting a dispersing medium into the measuring cell, means for injecting a specimen into the measuring cell, a first stirring means for stirring the contents in the measuring cell, a second stirring means for stirring the contents in the measuring cell, a measuring system for optically measuring the agglutinated degree of the contents in the measuring cell, and a control system of demanding continuation or termination of the stirring based on optical data obtained about the dispersed state of the stirred contents in the measuring cell. An apparatus for performing the method according to any of the claims 1 to 5, said apparatus comprises: means for supporting said measuring cell containing said solid fine particles, means for injecting a dispersing medium into the measuring cell, means for injecting a specimen into measuring cell, a stirring means for stirring the contents in the measuring cell, a mechanism for changing the stirring competence of said stirring means, a measuring system for optically measuring the degree of the agglutinated state of the contents in the measuring cell, and a control system of demanding continuation or termination of the stirring based on optical data obtained about the dispersed state of the stirred contents in said measuring cell. A method for measuring an immunologically active material by physically or chemically immobilizing a material immunologically active material to a material to be measured of a specimen to solid fine particles, reacting said immunologically active material immobilized on said solid fine particles with said specimen in a liquid medium to cause a reaction mixture in an agglutinated state and optically measuring said agglutinated state of the reaction mixture, characterized by including the steps of: (i) introducing a dispersing medium into a reaction cell containing dehydrated solid fine particles having a material, immunologically active to a material to be measured of a specimen, being physically or chemically immobilized on the surfaces of said fine particles (these dehydrated solid fine particles will be hereinafter referred to a "dry reagent fine-particles"), (ii) stirring said dispersing medium and said dry reagent fine particles while optically measuring the state of said dry reagent fine particles being dispersed in said dispersing medium, (iii) observing the dispersed state of said dry reagent fine particles in said dispersing medium on the basis of the optically measured results obtained in the step (ii) and terminating the stirring of the step (ii) when a predetermined dispersed state is provided, (iv) adding said specimen to the disposed body in the predetermined dispersed state, mixing and reacting them to cause a reaction mixture in an agglutinated state, (v) flowing the reaction mixture caused in the reaction cell in the step (iv) into a measuring cell, and (vi) optically measuring the agglutinated state of the reaction mixture in the measuring cell, wherein the step (iii) of observing the dispersed state of the dry reagent fine particles in the dispersing medium is performed by confirming if the ratio of an index A obtained by the equation (1): A=logIo/I versus an index Ao obtained by the equation (2): Ao=logI'o/I' satisfies the equation: A/Ao≦1.1, wherein the equation (1) is of the dry reagent particles dispersed body obtained in the step (ii), Io is an intensity of incident monochromatic light upon passing through the reaction cell containing said dispersed body and I is an intensity of light transmitted or scattered at that time, and wherein the equation (2) is of the reference standard dry reagent particles dispersed body, I'o is an intensity of incident monochromatic light upon passing through the reaction cell containing said standard dispersed body and I' is an intensity of light transmitted or scattered at that time. The method according to claim 8, wherein the step (vi) of optically measuring the agglutinated state of the reaction mixture is carried out by diluting said reaction mixture with a diluting agent and flowing the diluted reaction mixture into a flow cell. An apparatus for performing the method according to any of the claims 8 or 9, said apparatus comprises: means for supporting said reaction cell containing said solid fine particles, means for injecting a dispersing medium into the reaction cell, means for injecting said specimen into the reaction cell, a first stirring means for stirring the contents in the reaction cell, a second stirring means for stirring the contents in the reaction cell, a measuring system for optically measuring the degree of the dispersed state of the stirred solid fine particles in said dispersing medium in the reaction cell, a control system of demanding continuation or termination of the stirring based on optical date obtained about said dispersed state of the solid fine particles, a measuring cell for measuring the reaction mixture being supported by a measuring cell-supporting means, means for introducing the reaction mixture into said measuring cell, and a system for measuring the degree of the agglutinated state of the reaction mixture introduced into said measuring cell.

Inventors: MIYAZAKI TAKESHI, OKAMOTO TADASHI, SAKURANAGA MASANORI, TANAKA KAZUMI, MIYAZAKI, TAKESHI, OKAMOTO, TADASHI, SAKURANAGA, MASANORI, TANAKA, KAZUMI, MIYAZAKI, TAKESHI, C/O CANON KABUSHIKI KAISHA, OKAMOTO, TADASHI, C/O CANON KABUSHIKI KAISHA, SAKURANAGA, MASANORI, C/O CANON KABUSHIKI KAISHA, TANAKA, KAZUMI, C/O CANON KABUSHIKI KAISHA
Applicants: CANON KK, CANON KABUSHIKI KAISHA
Application year: 1990
Main classification: G01N33
IPC codes: G01N35, G01N33, G01N21